HRP20000585B1 - Substituted bisindolymaleimides for the inhibition of cell proliferation - Google Patents

Substituted bisindolymaleimides for the inhibition of cell proliferation

Info

Publication number
HRP20000585B1
HRP20000585B1 HR20000585A HRP20000585A HRP20000585B1 HR P20000585 B1 HRP20000585 B1 HR P20000585B1 HR 20000585 A HR20000585 A HR 20000585A HR P20000585 A HRP20000585 A HR P20000585A HR P20000585 B1 HRP20000585 B1 HR P20000585B1
Authority
HR
Croatia
Prior art keywords
bisindolymaleimides
inhibition
substituted
cell proliferation
methyl
Prior art date
Application number
HR20000585A
Other languages
English (en)
Croatian (hr)
Inventor
Hooda Dhingra Urvashi
Mary Huryn Donna
Ke June
Federico Weber Giuseppe
Original Assignee
F. Hoffmann - La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann - La Roche Ag filed Critical F. Hoffmann - La Roche Ag
Publication of HRP20000585A2 publication Critical patent/HRP20000585A2/hr
Publication of HRP20000585B1 publication Critical patent/HRP20000585B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20000585A 1998-03-17 2000-09-06 Substituted bisindolymaleimides for the inhibition of cell proliferation HRP20000585B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7833198P 1998-03-17 1998-03-17
PCT/EP1999/001534 WO1999047518A1 (en) 1998-03-17 1999-03-10 Substituted bisindolymaleimides for the inhibition of cell proliferation

Publications (2)

Publication Number Publication Date
HRP20000585A2 HRP20000585A2 (en) 2001-08-31
HRP20000585B1 true HRP20000585B1 (en) 2009-02-28

Family

ID=22143350

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000585A HRP20000585B1 (en) 1998-03-17 2000-09-06 Substituted bisindolymaleimides for the inhibition of cell proliferation

Country Status (34)

Country Link
US (1) US6048887A (de)
EP (1) EP1064279B1 (de)
JP (2) JP5026633B2 (de)
KR (1) KR100659411B1 (de)
CN (1) CN1127500C (de)
AR (1) AR018162A1 (de)
AT (1) ATE243693T1 (de)
AU (1) AU755673B2 (de)
BR (1) BR9908882A (de)
CA (1) CA2322689C (de)
CO (1) CO5070675A1 (de)
CZ (1) CZ299068B6 (de)
DE (1) DE69909068T2 (de)
DK (1) DK1064279T3 (de)
ES (1) ES2203111T3 (de)
HK (1) HK1036452A1 (de)
HR (1) HRP20000585B1 (de)
HU (1) HU228831B1 (de)
ID (1) ID26353A (de)
IL (1) IL138247A (de)
MA (1) MA26613A1 (de)
MY (1) MY121046A (de)
NO (1) NO320306B1 (de)
NZ (1) NZ506476A (de)
PE (1) PE20000340A1 (de)
PL (1) PL195323B1 (de)
PT (1) PT1064279E (de)
RS (1) RS49965B (de)
RU (1) RU2208612C2 (de)
SA (1) SA99191295B1 (de)
TR (1) TR200002580T2 (de)
TW (1) TW539676B (de)
WO (1) WO1999047518A1 (de)
ZA (1) ZA992072B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1064279B1 (de) * 1998-03-17 2003-06-25 F.Hoffmann-La Roche Ag Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
WO2001027106A1 (en) * 1999-10-12 2001-04-19 F. Hoffmann-La Roche Ag Substituted pyrroles as antiproliferative agents for the treatment of cancer
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
US7129250B2 (en) * 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
US6469179B1 (en) 2000-10-03 2002-10-22 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6482847B2 (en) 2000-10-03 2002-11-19 Hoffmann-La Roche Inc. Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
US6548531B2 (en) 2001-02-09 2003-04-15 Hoffmann-La Roche Inc. Method for cancer therapy
WO2002102373A1 (en) * 2001-06-15 2002-12-27 F. Hoffmann-La Roche Ag Method for administration of cancer therapeutic
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
WO2008117935A1 (en) * 2007-03-28 2008-10-02 Industry-Academic Cooperation Foundation, Yonsei University Nk cell activating molecules, nk cells and pharmaceutical compositons comprising the same
CN102924437B (zh) * 2012-11-19 2014-07-02 东华大学 3-哌嗪基-4-吲哚马来酰亚胺化合物及其制备和应用
WO2019000224A1 (zh) * 2017-06-27 2019-01-03 中国海洋大学 双吲哚马来酰亚胺衍生物及其制备方法和用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0328026A1 (de) * 1988-02-10 1989-08-16 F. Hoffmann-La Roche Ag Substituierte Pyrrole
WO1998004551A1 (en) * 1996-07-29 1998-02-05 F. Hoffmann-La Roche Ag Substituted bisindolylmaleimides for the inhibition of cell proliferation
WO1998004552A1 (en) * 1996-07-29 1998-02-05 F. Hoffmann-La Roche Ag Substituted bisindolylmaleimides for the inhibition of cell proliferation
WO1998004553A1 (en) * 1996-07-29 1998-02-05 F.Hoffmann-La Roche Ag Substituted bisindolylmaleimides for the inhibition of cell proliferation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DK0817627T3 (da) * 1993-12-23 2005-06-06 Lilly Co Eli Inhibitorer af proteinkinase C
EP1064279B1 (de) * 1998-03-17 2003-06-25 F.Hoffmann-La Roche Ag Substituierte bisindolylmaleimide zur inhibierung der zellproliferation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0328026A1 (de) * 1988-02-10 1989-08-16 F. Hoffmann-La Roche Ag Substituierte Pyrrole
WO1998004551A1 (en) * 1996-07-29 1998-02-05 F. Hoffmann-La Roche Ag Substituted bisindolylmaleimides for the inhibition of cell proliferation
WO1998004552A1 (en) * 1996-07-29 1998-02-05 F. Hoffmann-La Roche Ag Substituted bisindolylmaleimides for the inhibition of cell proliferation
WO1998004553A1 (en) * 1996-07-29 1998-02-05 F.Hoffmann-La Roche Ag Substituted bisindolylmaleimides for the inhibition of cell proliferation

Also Published As

Publication number Publication date
PE20000340A1 (es) 2000-05-13
ATE243693T1 (de) 2003-07-15
MY121046A (en) 2005-12-30
ID26353A (id) 2000-12-14
DE69909068D1 (de) 2003-07-31
AU755673B2 (en) 2002-12-19
DK1064279T3 (da) 2003-10-06
NO20004579D0 (no) 2000-09-14
JP5026633B2 (ja) 2012-09-12
HUP0101258A2 (hu) 2001-10-28
TR200002580T2 (tr) 2000-11-21
NO320306B1 (no) 2005-11-21
CN1127500C (zh) 2003-11-12
AU3409999A (en) 1999-10-11
EP1064279B1 (de) 2003-06-25
AR018162A1 (es) 2001-10-31
BR9908882A (pt) 2000-11-21
MA26613A1 (fr) 2004-12-20
IL138247A (en) 2005-08-31
PT1064279E (pt) 2003-10-31
CA2322689A1 (en) 1999-09-23
JP2002506864A (ja) 2002-03-05
SA99191295B1 (ar) 2006-04-26
US6048887A (en) 2000-04-11
NZ506476A (en) 2003-12-19
ZA992072B (en) 1999-09-22
HU228831B1 (en) 2013-05-28
RS49965B (sr) 2008-09-29
TW539676B (en) 2003-07-01
IL138247A0 (en) 2001-10-31
YU55200A (sh) 2002-11-15
CN1293671A (zh) 2001-05-02
NO20004579L (no) 2000-09-14
EP1064279A1 (de) 2001-01-03
ES2203111T3 (es) 2004-04-01
WO1999047518A1 (en) 1999-09-23
HK1036452A1 (en) 2002-01-04
PL342964A1 (en) 2001-07-16
CZ20003384A3 (cs) 2000-12-13
KR100659411B1 (ko) 2006-12-18
CZ299068B6 (cs) 2008-04-16
CO5070675A1 (es) 2001-08-28
JP2010222366A (ja) 2010-10-07
RU2208612C2 (ru) 2003-07-20
KR20010041995A (ko) 2001-05-25
HUP0101258A3 (en) 2002-08-28
HRP20000585A2 (en) 2001-08-31
CA2322689C (en) 2008-11-25
PL195323B1 (pl) 2007-09-28
DE69909068T2 (de) 2004-05-06

Similar Documents

Publication Publication Date Title
HRP20000585B1 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
YU35697A (en) Substituted 6,6-hetero-bicyclic derivatives
RS49688B (sr) Novi derivat 3-aril-2- hidroksipropionske kiseline (i)
CA2293247A1 (en) 4-phenylpiperidine compounds
TR199700419A2 (xx) Yeni piridazinon t�revleri.
DK1485359T3 (da) Natriumkanalblokkere
RS50145B (sr) Tetrahidropiridoetri
HRP20000292B1 (en) 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
DK1052984T3 (da) Antibakterielle midler
RS49531B (sr) Estrogen agonisti/antagonisti
ATE297203T1 (de) Antithrombotische mitteln
EP0513387A4 (en) Active oxygen inhibitor
ATE306261T1 (de) Antithrombosemittel
AP2002002637A0 (en) Novel piperazine
ATE194336T1 (de) Morpholin tachykinin rezeptor antagonisten
RS51200B (sr) (imidazol-1-il-metil)-piridazin kao blokator nmda receptora
RS53428B (en) COMPOSITIONS AND ANTI-VIRUS ACTIVITY OF SUBSTITUTED AZAINDOLOXOSCETER PIPERAZINE DERIVATIVES
RS49792B (sr) Piperidinilaminometil trifluorometil ciklična etarska jedinjenja kao antagonisti supstance
RS50229B (sr) Analozi vitamina d3
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
DE69709933D1 (en) Aromatische amidinderivate als selektive thrombininhibitoren
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
YU7191A (sh) Oralno aktivni inhibitori renina
NO981393D0 (no) Guanidinoproteasehemmere
ES2152379T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20180306

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20190310